help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bikle, D. D.
Right arrow Articles by Gee, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bikle, D. D.
Right arrow Articles by Gee, E.

Endocrinology, Vol 124, 649-654, Copyright © 1989 by Endocrine Society


ARTICLES

Free, and not total, 1,25-dihydroxyvitamin D regulates 25- hydroxyvitamin D metabolism by keratinocytes

DD Bikle and E Gee
Department of Medicine, Veterans Administration Medical Center, San Francisco, California 94121.

Greater than 99% of the total circulating 1,25-dihydroxyvitamin D [1,25- (OH)2D] is bound to proteins such as the vitamin D-binding protein (DBP) and albumin; in the normal human only 0.4% of the circulating 1,25-(OH)2D is free. Although it is often assumed that only the free concentration of 1,25-(OH)2D is available to cells, this has not been demonstrated. In particular, it is not clear whether the DBPs facilitate 1,25-(OH)2D entry into target cells or serve only to transport these metabolites within the circulation. To address this question, we evaluated one of the best characterized target tissue responses to 1,25-(OH)2D, namely its ability to inhibit its own production and induce that of 24,25-(OH)2D, using one of the most sensitive cells, the human foreskin keratinocyte. We incubated keratinocytes in the presence of 1,25-(OH)2D (from 10(-11)-10(-8) M) in medium containing albumin (from 0.1-10%) or serum (from 0.1-10%) for 4 h [to inhibit the 25-hydroxyvitamin D (250HD) 1 alpha-hydroxylase] or 16 h (to induce the 250HD 24-hydroxylase) before evaluating [3H]250HD metabolism by these cells during a 1-h incubation in serum- and albumin- free medium. The free fraction of 1,25-(OH)2D was determined in each medium by centrifugal ultrafiltration and varied from 36% to 0.57% in direct proportion to the albumin or serum in the medium. Increasing the serum or albumin concentration in the medium increased the concentration of total 1,25-(OH)2D needed to inhibit its own production or stimulate that of 24,25-(OH)2D. In contrast, the concentration of free 1,25-(OH)2D needed to half-maximally inhibit its own production or induce 24,25-(OH)2D production remained constant at approximately 10(- 11) M. We conclude that the free, not the total, 1,25-(OH)2D concentration regulates 250HD metabolism by keratinocytes, that DBPs do not facilitate 1,25-(OH)2D entry into the cell, and that these cells sense only free 1,25-(OH)2D.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
G. Jones
Pharmacokinetics of vitamin D toxicity
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 582S - 586S.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Z. H. Al-oanzi, S. P. Tuck, N. Raj, J. S. Harrop, G. D. Summers, D. B. Cook, R. M. Francis, and H. K. Datta
Assessment of Vitamin D Status in Male Osteoporosis
Clin. Chem., February 1, 2006; 52(2): 248 - 254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. S. Dusso, A. J. Brown, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F8 - F28.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Inaba, H. Morii, T. Katsumata, H. Goto, E. Ishimura, T. Kawagishi, M. Kamao, T. Okano, and Y. Nishizawa
Hyperparathyroidism Is Augmented by Ovariectomy in Nagase Analbuminemic Rats
J. Nutr., June 1, 2000; 130(6): 1543 - 1547.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. J. Brown, A. Dusso, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol, August 1, 1999; 277(2): F157 - F175.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Brown
Regulation of vitamin D action
Nephrol. Dial. Transplant., January 1, 1999; 14(1): 11 - 16.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society